Atlas Trials

Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)

Clinical trial NCT02911597 · COMPLETED

Trial details

NCT number
NCT02911597
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Depression
Start date
2016-09-01
Primary completion
2018-02-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.